젠큐릭스 소식을 전합니다.


젠큐릭스의 새로운 소식을 알려드립니다.

보도자료 New diagnostics development hub launched to improve healthcare treatme…

페이지 정보

작성자 최고관리자 댓글 0건 조회 9,668회 작성일 14-12-04 11:27


By Claire 

26 Nov2:49 PM
THE Diagnostics Development (DxD) Hub was launched on Wednesday to cater to the rapidly growing demand for devices that will make it faster and easier for healthcare professionals to make more immediate diagnosis and improve treatment outcome for patients.
Described as a "major boost" to Singapore's biomedical research, the hub aims to develop medical diagnostics as part of the medical technologies industry. It also aims to improve healthcare through development of related solutions and accelerate development of new diagnostics devices. 
Led by the Agency for Science, Technology and Research (A*STAR), the hub will bring clinicians, researchers, entrepreneurs and industry professionals onto a common platform to fast track the development of clinically-proven, market-ready diagnostic tools and solutions. 
The DxD Hub on Wednesday marked its opening with the unveiling of multiple partnerships across both public and private sectors. 
They include collaborations with the healthcare and academic medical community including SingHealth, National University Health System, National Healthcare Group, as well as academic research organisations like the Singapore Clinical Research Institute. 
Multinational companies such as Johnson & Johnson Innovation and Thermo Fisher Scientific, along with small and medium-sized enterprises and start-ups such as AITbiotech and Gencurix, are also among the early supporters of the DxD Hub.
The hub was launched by S Iswaran, Minister in the Prime Minister's Office, at Biopolis. Mr Iswaran is also the Second Minister for Home Affairs, as well as for Trade and Industry.
Diagnostics is one of four innovation clusters shortlisted to be funded under the S$200 million Innovation Cluster Programme (ICP) which was announced last October.


젠큐릭스 싱가포르 진출을 위해 The Diagnostics Development Hub(DxD Hub)와 급격히 성장중인 진단분야에 있어 협력관계를 구축

 젠큐릭스는2014년 11월 세계적인 기업인Johnson & Johnson Innovation  Thermo Fisher Scientific등이 참여한 DxD Hub 행사에 함께 참여하여 의료진단 분야와 새로운 진단장비의 개발을 위해 노력하고 있음

 본 사업에서 진단분야는 2억달러(싱가포르 달러규모의 ICP라는Innovation Cluster Programme  4가지 혁신 사업중의 하나이다.